Loading

The development of N-Acetyl-Carnosine - NAC

Innovative Vision Products (IVP) is a US based corporation, operating in Russia, where under the guidance of Dr Mark Babizhayev, researchers and scientists have, over many years, developed a new form of carnosine known as n-acetylcarnosine or NAC. Dr. Mark Babizhayev is the senior research investigator at the prestigious Helmholtz Institute for Ocluar Disease and the founder of IVP.

IVP have developed a proprietary method of producing extremely high purity NAC. This NAC presents the first major leap forward in the treatment and possible prevention of senile cataract and other aging eye conditions without the need of potentially risky operations or intrusive medical procedures.

IVP has worldwide patents for its high purity NAC including its use for cataracts. IVP's NAC has a highly statistical and very significant clinical success rate for patients within 3-12 months of treatment.

In the last decade, IVP's NAC (branded as Can-C eye drops) has generated thousands of reports of safe and effective cataract reversal in both humans and in animals . Early studies in Russia had patients instilling 2 drops of Can-C eye drops into each eye several times a day, for a period of 6 months. The effective rate was 100% setting an unprecedented benchmark for the treatment and reversal of cataracts and other eye disorders.

Initial results are often found after 3 months usage but optimal cataract reversal is usually achieved between 6 – 12 months. Results are often dependant on the severity of the cataract before the commencement of treatment.

"We see the demand for this breakthrough product snowballing as consumers around the globe become aware of a viable non-surgical option to cataract surgery.." - Innovative Vision Products.

Research has shown that Can-C Eye Drops applied for 6-months, at a rate of twice daily into the effected eye generated the following results:

90% had an improvement in visual acuity.

88.9% had an improvement of glare sensitivity.

41.5% had an improvement of the transmissivity of the lens.

Of course Can-C isn't just for senile cataracts, this powerful eye antioxidant has many benefits for aging eyes serving many complaints and disorders such as:

Intraocular pressure associated with glaucoma.

Contact lens disorders.

Presbyopia

Corneal disorders.

Chronic eyestrain.

Computer vision syndrome.

Ocular inflammation.

Blurred vision.

Dry eye syndrome.

Retinal disease

Vitreous opacities and lesions.

Soothing Can-C eye-drops also help to make wearing contact lenses more comfortable due to its action in the reduction of lactic acid in the eye which enables the lens to be left safely in the eye for longer.

Can-C- Two (5ml) vials per box.

Apply 4 drops daily to each affected eye.

1 month supply for one eye = 1 box

Can-C is Manufactured in a GMP certified, pharmaceutical facility which meets ISO 9001:2000 and ISO 13485:2003 standards for the design/formulation and manufacture of sterile contact lens solution and pharmaceutical solutions.

Disclaimer: The Food and Drug Administration have not evaluated the statements contained herein. This product is not intended to diagnose, treat, cure or prevent any disease.